Joong-Myung Cho
Independent DirectorDr. Joong-Myung Cho, Ph.D. has been Chairman and CEO of CG Pharmaceuticals, Inc. since October 2008. Dr. Cho is Independent Director of OSR Health, Inc. (formerly known as OSR Holdings, Inc.) from February 14, 2025. Dr. Cho previously served as Chairman and CEO of Hwail Pharmaceuticals Co. Ltd. from August 2013 to December 2022. He serves as Independent Director at Valuence Merger Corp. I since March 2022. Dr. Cho served as Founder, Chief Executive Officer and President at CG Invites Co., Ltd. (formerly known as CrystalGenomics Invites Co., LTD.) (formerly known as CrystalGenomics, Inc.) from July 2000 to March 2023. Dr. Cho was Chairman of CG Invites Co., Ltd. (formerly known as CrystalGenomics Invites Co., LTD.) (formerly known as CrystalGenomics, Inc.) from July 2000 to March 2023 and has experience in the biopharmaceuticals industry from R&D to commercialization of novel drugs and is a global leading life sciences expert. Dr. Cho previously served as Co-Chief Executive Officer at SILLA SG Co., Ltd. Dr. Cho has previously served as the Executive Senior Vice President and Director of R&D Biotech Research Institute at LG Life Sciences (formerly LG Chem)from 1984 to 2000. During his tenure, the biopharmaceutical institute at LG became one of the leading life science companies in the world, growing from just a few research scientists to several hundred employees. He has successfully introduced 10 different recombinant products such as growth hormones of human, bovine and porcine, hepatitis B vaccine, interferon alpha and gamma, granulocyte-macrophage colony-stimulating factor and sargramostim, erythropoietin, among others. Moreover, four drug candidates were out-licensed to multinational pharmaceutical companies under his supervision, with one gaining approval from the U.S. Food and Drug Administration (FDA). On the basis of such achievements, Dr. Cho has received many awards. Dr. Cho received his Ph.D. from the University of Houston and worked as a post-doctorate fellow at the Baylor College of Medicine. Dr. Cho is an author of more than 80 publications, including a cover-page publication in Nature magazine and has more than 200 filed patents.
Positions
- Company NameValuence Merger Corp. IStock CodeVMCAFPositionIndependent DirectorRelated Securities
